Pharmacogenetics

Human Molecular Genetics

Volumn 10, Issue 20, 2001, Pages 2261-2267

  Roses, A D ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DRUG; ENZYME;

ADVERSE DRUG REACTION; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DNA FINGERPRINTING; DRUG EFFICACY; DRUG METABOLISM; DRUG RESPONSE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ETHNIC GROUP; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; INHERITANCE; PHARMACOGENETICS; PRIORITY JOURNAL; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0035474758     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/10.20.2261     Document Type: Article

References (29)

1. Pharmacogenetics and psychopharmacotherapy
2. An introduction to drug disposition: The basic principles of absorption, distribution, metabolism, and excretion
3. Advances in pharmacogenetics and pharmacogenomics
4. Pharmacogenetics and future drug development and delivery
5. Pharmacogenetics and the practice of medicine
6. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
7. Huntington's disease and repeating trinucleotides
8. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease
9. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
10. Linkage studies in familial Alzheimer's disease: Evidence on chromosome 19 linkage
11. A 4-Mb high-density single nucleotide polymorphism-based map around human APOE
12. SNPing away at complex diseases: Analysis of single nucleotide polymorphisms around APOE in Alzheimer disease
13. Pharmacogenetics and the practice of medicine
14. Genetic associations
15. Apolipoprotein E genotyping in Alzheimer's disease (consensus statement of the National Institute of Aging/Alzheimer's Association Working Group)
16. Apolipoprotein E, a complex gene with biological interactions in the aging brain
17. Human apolipoprotein E2, E3 and E4 isoform specific transgenic mice: Human-like pattern of neuronal immunoreactivity in central nervous system not observed in wild type mice
18. Haplotypes at ATM identify coding-sequence variation and indicate a region of extensive linkage disequilibrium
19. Allele association studies with SSR and SNP markers at known physical distances within a 1 Mb region embracing the ALDH2 locus in the Japanese, demonstrates linkage disequilibrium
20. Identification of a psoriasis susceptibility candidate gene by linkage disequilibrium mapping with a localised single nucleotide polymorphism map
21. Single nucleotide polymorphism (SNP) alleles in the Insulin Receptor (INSR) gene are associated with typical migraine
22. Extracting and visualizing matrix-assisted laser desorption/ionization time of flight mass spectral fingerprints
23. Electrospray ionization and matrix-assisted laser desorption ionization mass spectrometry. Emerging technologies in biomedical sciences
24. MALDI TOF mass spectroscopy: An emerging platform for genomics and diagnostics
25. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms
26. Molecular diagnostics: A powerful new component of the healthcare value chain
27. Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: Comparison of immunohistochemistry assay with fluorescence in situ hybridisation assays
28. Current and planned clinical trails with trastuzumab
29. How pharmacogenetics will affect the practice of neurology